FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 331:1533-1534 December 1, 1994 Number 22 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

(Current Clinical Oncology.) Edited by Nancy A. Dawson and Nicholas J. Vogelzang. 288 pp., illustrated. New York, Wiley-Liss, 1994. $74.95. ISBN 0-471-58834-2.

Prostate cancer is now the most common type of cancer among American men. Over the past few years, new forms of technology such as prostate-specific-antigen (PSA) testing and transrectal ultrasonography have permitted the early detection of prostate cancer in asymptomatic men. The American Cancer Society recommends that men over 50 years of age have a yearly rectal examination and PSA measurement. Mass screening of this population has profoundly changed the incidence of diagnosed prostate cancer -- from 105,000 in 1990 to 165,000 in 1993. An estimated 200,000 cases of prostate cancer will be diagnosed in the year 2000.

These statistics . . . [Full Text of this Article]

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.